Index tracked: Prezzo di riferimento di HYPE — CCData Aggregated Index (fonte: 21Shares)
TER
2.50%
Fund size
37 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%ETC/ETN: «redditi diversi»
Income
Accumulating
Launch 28 Aug 2025 · costs from the KID as of 17 Aug 2026 · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 19 Aug 2026
Price data (in USD) from Kaiko Indices is used to calculate the price of the underlying asset(s). Collateral Agent Law Debenture Trust Corporation p.l.c. Additional Information Updated and additional documents on the product, in particular the prospectus, the final terms, supplements and financial statements are published on the company website https://21shares.com/ir in accordance with the relevant legal provisions. It is recommended that you read these documents for more information, particularly on the structure of the product and the risks associated…
Performance since series start (in euro) — base 100
28 Aug 2025 → 4 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 171 (1 Sept 2026) · low 43 (22 Jan 2026) · last 170. Past performance is not indicative of future results.
RebalixHYPE · CH1471826029 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: under review: fund and index diverge by more than 3 points over 12 months (-4.32 pp) — fund and index may be of different nature (price/total return, currency)
The live sheet, always up to date rebalix.com/en/etf/CH1471826029 Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.